Core Viewpoint - The company, Hainan Puli Pharmaceutical Co., Ltd., has announced a potential downward adjustment of the conversion price for its convertible bonds due to the stock price falling below a specified threshold over a recent trading period [1][10]. Group 1: Convertible Bond Details - The company issued 8.5 million convertible bonds with a face value of 100 RMB each, raising a total of 850 million RMB, netting approximately 837.86 million RMB after fees [2][4]. - The conversion period for the bonds started on August 23, 2021, and will last until the bonds mature [4]. - The initial conversion price was set at 46.22 RMB per share, which has been adjusted multiple times due to various corporate actions [6][7]. Group 2: Price Adjustment Conditions - According to the bond's offering document, if the stock price falls below 85% of the conversion price for at least 15 out of 30 consecutive trading days, the board can propose a downward adjustment of the conversion price [10][11]. - As of the period from March 17, 2025, to May 9, 2025, the stock has recorded 10 trading days where the closing price was below 2.55 RMB, indicating a potential trigger for the price adjustment [1][10]. Group 3: Future Implications - If the downward adjustment condition is triggered, the company will follow the necessary procedures for board review and shareholder voting as outlined in the offering document [11][12]. - The company has a timeline for the delisting of its stock, with a trading suspension expected to last for 15 days, concluding on May 21, 2025 [1].

Core Viewpoint - Hainan Puli Pharmaceutical Co., Ltd. announced that its stock and convertible bonds will be delisted, with the delisting period starting on April 28, 2025, and expected to last until May 21, 2025 [1][2][3] Group 1: Delisting Information - The convertible bonds will enter a delisting adjustment period for fifteen trading days, with the last trading date anticipated to be May 21, 2025 [1] - After the delisting, the company's stock and convertible bonds will be managed by the National Equities Exchange and Quotations (NEEQ) in a delisting board for transfer [3] - The Shenzhen Stock Exchange has decided to terminate the listing of the company's stock and convertible bonds as of April 18, 2025 [2] Group 2: Management and Compliance - The company is required to appoint a securities firm to provide services for the transfer of its stock and convertible bonds in the delisting board [3][4] - The company has signed an agreement with Guotai Junan Securities Co., Ltd. to act as the main underwriter for the transfer of its stock and convertible bonds [4] - The appointed underwriter will handle various administrative tasks, including registration and confirmation of shares and bonds in the delisting board [4][5]

| 证券代码：300630 | 证券简称：普利退 公告编号：2025-053 | | --- | --- | | 债券代码：123099 | 债券简称：普利转退 | 海南普利制药股份有限公司 关于可转换公司债券预计触发转股价格向下修正条件的 提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、证券代码：300630 证券简称：普利退 2、债券代码：123099 债券简称：普利转退 3、转股价格：3.00 元/股 4、转股期限：2021 年 8 月 23 日至 2027 年 2 月 8 日 5、根据《海南普利制药股份有限公司创业板向不特定对象发行可转换公司 债券募集说明书》（以下简称"募集说明书"）规定："在本可转债存续期间， 当海南普利制药股份有限公司（以下简称"公司"）股票在任意连续三十个交易 日中至少有十五个交易日的收盘价低于当期转股价格的 85%时，公司董事会有 权提出转股价格向下修正方案并提交公司股东大会表决。" 自 2025 年 3 月 17 日至 2025 年 5 月 9 日期间，公司股票已有 10 个交易日 的收盘价格低于 ...

| 证券代码：300630 | 证券简称：普利退 | 公告编号：2025-052 | | --- | --- | --- | | 债券代码：123099 | 债券简称：普利转退 | | 海南普利制药股份有限公司 关于聘请主办券商的公告 特别提示： 1. 海南普利制药股份有限公司（以下简称"公司"）股票及可转换公司债 券（以下简称"可转债"）进入退市整理期的起始日为 2025 年 4 月 28 日，退市 整理期为十五个交易日，预计最后交易日期为 2025 年 5 月 21 日。公司股票及 可转债于退市整理期届满的次一交易日摘牌并终止上市。 2. 公司股票及可转债在退市整理期交易期间，公司将不筹划或实施重大资 产重组。可转债在退市整理期的相关交易规则、投资者适当性安排请投资者查 阅《关于可转换公司债券退市整理期间交易安排的通知》（深证上〔2023〕492 号）及《关于完善可转换公司债券投资者适当性管理相关事项的通知（2025 年 修订）》（深证上〔2025〕223 号）。 3. 请投资者、证券公司等市场主体在股票摘牌前及时了结股票质押式回购、 约定购回、融资融券、转融通、深股通等业务。 4. 对于将在股票摘牌后至 ...

New Stock Offerings - ST Xinchao (600777) is in the offer period from April 23, 2025, to May 22, 2025[1] - Puli Tui (300630) has 8 trading days remaining until the last trading day[1] - ST Zhongcheng (300208) is also in the offer period with announcements made on April 29, 2025[1] Trading Alerts - ST Yushun (002289) has reported severe abnormal fluctuations as of April 29, 2025[1] - ST Keli Da (603828) has an announcement dated May 9, 2025, regarding trading alerts[1] - ST Yuan Cheng (603388) has similar trading alerts as of May 9, 2025[1] Market Trends - The report indicates a significant number of stocks under abnormal trading conditions, suggesting increased market volatility[2] - Multiple stocks are approaching their last trading days, indicating potential liquidity issues for investors[1] - The overall trend shows a heightened level of scrutiny on stocks with abnormal fluctuations, which may impact investor confidence[2]

| 证券代码：300630 | 证券简称：普利退 | 公告编号：2025-051 | | --- | --- | --- | | 债券代码：123099 | 债券简称：普利转退 | | 海南普利制药股份有限公司 关于公司股票及可转换公司债券进入退市整理期交易的 特别提示： 1. 海南普利制药股份有限公司（以下简称"公司"）股票及可转换公司债 券（以下简称"可转债"），于退市整理期届满的次一交易日摘牌，公司股票及 可转债终止上市。 2. 公司股票及可转债进入退市整理期的起始日为 2025 年 4 月 28 日，预计 最后交易日期为 2025年 5月 21日。公司可转债自 2025年 4月 28日起恢复转股。 3. 公司股票及可转债将在退市整理期交易十五个交易日，截至 2025 年 5 月 7 日公司股票及可转债已交易 5 个交易日，剩余 10 个交易日，交易期满将被 终止上市，敬请投资者审慎投资、注意风险。 4. 公司股票及可转债在退市整理期交易期间，公司将不筹划或实施重大资 产重组。可转债在退市整理期的相关交易规则、投资者适当性安排请投资者查 阅《关于可转换公司债券退市整理期间交易安排的通知》（深证上〔202 ...

Summary of Key Points Core Viewpoint - The A-share market shows a significant number of low-priced stocks, with 63 stocks priced below 2 yuan, indicating a potential area for investment analysis and opportunities in the market [1]. Group 1: Market Overview - As of May 6, the Shanghai Composite Index closed at 3316.11 points, with an average A-share price of 11.34 yuan [1]. - The distribution of high-priced and low-priced stocks is relatively small in the overall A-share market [1]. Group 2: Low-Priced Stocks - Among the 63 stocks priced below 2 yuan, the lowest is *ST Jiayao at 0.21 yuan, followed by *ST Pengbo at 0.62 yuan and Puli Tui at 0.69 yuan [1]. - 41.27% of the low-priced stocks are ST stocks, indicating a significant presence of companies under special treatment [1]. Group 3: Performance of Low-Priced Stocks - Out of the low-priced stocks, 49 stocks experienced an increase in price, with Guangtian Group leading at a rise of 9.94%, followed by Shanzi Gaoke at 6.18% and Baogang Co. at 5.78% [1]. - Conversely, 6 stocks saw a decline, with *ST Sihuan dropping by 5.24%, *ST Jinguang by 4.81%, and *ST Xingguang by 4.79% [1].

Core Viewpoint - The article discusses the recent updates on convertible bond ratings, highlighting that while most ratings remain unchanged, several have been downgraded due to deteriorating company fundamentals, including losses, increased debt pressure, and worsening credit conditions [1][3]. Group 1: Rating Updates - As of now, 72 convertible bonds have updated their ratings this year, with 65 bonds maintaining their previous ratings, accounting for 90.28% [3]. - Seven convertible bonds have experienced rating downgrades, including Dongshi Convertible Bond, Fumiao Convertible Bond, and others, primarily due to continuous losses and increased debt pressure [3][4]. Group 2: Reasons for Downgrades - Fumiao Convertible Bond's rating was adjusted from A+ to A due to declining profitability and increased debt pressure, with a significant rise in the asset-liability ratio expected by the end of 2024 [4]. - Dongshi Convertible Bond's rating was downgraded from B to CCC, reflecting increased liquidity risks and a negative outlook due to worsening credit conditions, including civil judgments and administrative penalties [5]. Group 3: Implications of Downgrades - The downgrades indicate a rise in credit risk for the affected convertible bonds, which could lead to potential liquidity issues and increased scrutiny from investors [6][7]. - The downgrade of the Puli Convertible Bond from BB to B+ was influenced by the termination of its stock and bond listings due to significant financial discrepancies, which severely impacted the company's market reputation [8][9]. - The company faces potential risks of early redemption of convertible bonds if stock prices fall below a certain threshold, exacerbating liquidity pressures and increasing the likelihood of default [10].

Market Overview - A-shares showed mixed performance in the three trading days leading up to the holiday, with the Shanghai Composite Index closing at 3279.03 points, down 0.49% for the week, while the Shenzhen Component Index fell 0.17% to 9899.82 points, and the ChiNext Index rose slightly by 0.04% to 1948.03 points [1] - Over 52% of stocks experienced gains during the week, with 74 stocks rising over 15% and 51 stocks declining more than 15% [1] Leading Stocks - The top-performing stock, Daye Co., Ltd. (300879.SZ), surged by 43.80%, followed closely by Jingjin Electric (688280.SH) with a 43.62% increase [1] - Other notable gainers included Chunguang Intelligent (838810.BJ), United Chemical (301209.SZ), Yuzhong Sanxia A (000565.SZ), and Hongbo Co., Ltd. (002229.SZ), all of which saw weekly gains exceeding 33% [1] Industry Insights - The lawn mower robot sector is anticipated to experience significant growth, with Daye Co., Ltd. being a key player in this market [1][3] - The global OPE market exceeds $30 billion, with the lawn mower segment valued at $20 billion and annual sales nearing 30 million units. However, the lawn mower robot market is currently only $2.6 billion, with annual sales between 1.2 million and 1.3 million units, indicating a low penetration rate of 12% in sales and 5% in volume [3] - Forecasts suggest that by 2030, lawn mower robot sales could reach between 5 million and 10 million units under optimistic and conservative scenarios, respectively [3] Company Performance - Daye Co., Ltd. has seen its stock price rebound over 95% since its low on April 8, with a total market capitalization of 5.7 billion yuan and a share price of 28.40 yuan as of April 30 [2] - The company reported a total revenue of 1.761 billion yuan for the year 2024, marking an increase of 89.67% year-on-year, and a net profit of 16.1152 million yuan, up 109.22% year-on-year [6] - In Q1 2025, the company achieved a revenue of 1.518 billion yuan, reflecting a year-on-year increase of 138.72%, with a net profit of 19.4 million yuan, up 326.94% year-on-year [6] Strategic Acquisitions - On February 12, Daye Co., Ltd. completed the acquisition of AL-KO for 20 million euros, which is expected to enhance its distribution channels in Europe and Australia and contribute approximately 130 million yuan to its performance by 2025 [4]

圳证券交易所申请股票全天停牌的，停牌期间不计入退市整理期，累计停牌天 数不得超过五个交易日。如股票交易日期出现调整，公司股票退市整理期最后 交易日期随之顺延。此外，公司股票停复牌的，可转债同时停复牌并暂停或者 恢复转股，股票因交易情况被实施盘中临时停复牌的除外。 | 证券代码：300630 | 证券简称：普利退 | 公告编号：2025-050 | | --- | --- | --- | | 债券代码：123099 | 债券简称：普利转退 | | 海南普利制药股份有限公司 关于公司股票及可转换公司债券进入退市整理期交易的第 二次风险提示暨无法在法定期限内披露定期报告的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1. 海南普利制药股份有限公司（以下简称"公司"）股票及可转换公司债 券（以下简称"可转债"）进入退市整理期交易的起始日为 2025 年 4 月 28 日， 预计最后交易日期为 2025 年 5 月 21 日。 3. 根据《创业板股票上市规则》第 10.7.2 条的规定，退市整理期的交易期 限为十五个交易日。公司股票在退市整理期内原则 ...